期刊文献+

胃肠道恶性肿瘤患者治疗前后血清CEA水平的动态分析 被引量:1

Dynamic analysis of the CEA level of patients with gastrointestinal cancer
下载PDF
导出
摘要 目的 :探讨治疗前后不同时期胃肠道恶性肿瘤患者血清CEA水平的变化规律及临床意义。方法 :采用CEA单克隆抗体酶联免疫检测试剂盒 ,检测患者血清CEA水平 ,用统计学方法对检测结果进行比较分析。结果 :胃肠道恶性肿瘤患者手术前CEA水平显著高于健康人(P<0.005) ,手术后CEA普遍降低至较低水平。当患者再进行化疗时 ,化疗结束后60天内81.8%(18/22)的患者血清CEA有升高现象 ;61天~180天再次复查时 ,其中13例患者CEA水平又降至化疗前的水平。结论 :手术治疗可降低胃肠道恶性肿瘤患者的血清CEA水平 ;化学药物治疗可使患者出现短暂的(60天内)、可恢复的血清CEA升高过程 ,在此期间内CEA值尚不能作为肿瘤复发或转移的指征。动态分析患者CEA水平对肿瘤诊断和疗效评价有重要意义 ,化疗后患者CEA水平升高的机制待进一步研究。 Objective:To explore the CEA level before and after treatment to assess its clinical significance in gastrointestinal cancer patients.Methods:The serum CEA were detected by CEA ELISA Kits.The results were analysed by statistics.Results:The serum CEA level of gastrointestinal cancer patients was higher than normal controls (P<0.005) and it decreased generally after operation.It would increase for a period (about two months) in 81.8% patients after chemotherapy,then it would decrease to the level before chemotherapy.Conclusion:The serum CEA level could decrease after operation and it would have a returnable increasing period after chemotherapy.During this period the CEA level couldn't be taken as a sign of recurrence and metastases.
出处 《四川肿瘤防治》 2000年第3期157-158,共2页 Sichuan Journal of Cancer Control
关键词 胃肠道恶性肿瘤 治疗 CEA gastrointestinal cancer therapy CEA
  • 相关文献

参考文献4

  • 1张天泽 徐光炜.肿瘤学(第1版)[M].天津:天津科学技术出版社,1996.1554.
  • 2肖远康 林苹 等.癌胚抗原单克隆抗体一酶免疫法测定癌患者血清中癌胚抗原水平的研究[J].华西医科大学学报,1987,18(1):33-35.
  • 3肖远康 陆燕蓉 等.癌胚抗原单克隆抗体在肺癌的应用[J].实用肿瘤杂志,1987,2(4):17-19.
  • 4潘跃银,张颖.测定胃癌术后患者血清CEA、CA_(50)及Cu/Zn比值的临床意义[J].实用癌症杂志,1996,11(1):7-9. 被引量:4

二级参考文献1

共引文献33

同被引文献8

  • 1Goldberg RM, Sargent DJ, Morton RF,et al. A randomize controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metstatic colorectal cancer[J]. J Clin Oncol,2004,22:23-30.
  • 2Sorbye H, Dahl O. Transient CEA increase at start of oxaliplatin combination therapy for metastatic colorectal cancer [J]. Acta Oncol, 2004,43 (5):495-498.
  • 3Trillet -Lenoir V, Freyer G, Kaemmerlen P, et al. Assessment of turnoutr response to chemotherapy for metastatic eoloreetal cancer: accuracy of the RECIST criterial [J], Br J Radiol,2002,75 (899): 903-908.
  • 4Wanebo HJ, Rao B,Pinsky CM,et al. Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer[J]. N Engl J Med,1978,299:448-451.
  • 5Engstrom PF, Benson AB 3rd,Chen YJ,et al. Colon cancer clinical practice guidelines in ontology[J]. J Natl Compr Canc Netw, 2005,3:468-491.
  • 6Bast RC, Ravdin P, Hayes DF, et al. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: Clinical practice guidelines of the American Society of Clinical Oncology [J]. J Clin Oncol,2001,19 : 1865 - 1878.
  • 7Ohtsukasa S, Okabe S, Yamashita H, et al. Increased expression of CEA and MHC class Ⅰ in colorectal cancer cell lines exposed to chemotherapy drugs [J]. J Cance Res Clin Oncol, 2003,129 : 719 - 726.
  • 8Aquino A, Formica V, Prete SP, et al. Drug - induced increase of carcinoembryonic antigen expression in cancer cells [J]. Pharmacol Res, 2004,49:383 - 396.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部